Pascal H P de Jong

74PUBLICATIONS
104CO-AUTHORS
Epidemiological modellingHaematological tumoursMedical infection agents (incl. prions)Rheumatology and arthritisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (74)

|Aug 10, 2026
Cost-effectiveness of secondary prevention of rheumatoid arthritis with methotrexate in the Netherlands: differences between developing ACPA-positive and ACPA-negative disease.

|May 04, 2026
Pre-arthritis stages of rheumatoid arthritis: from pathology to precision prevention.

|Mar 04, 2026
Modified Dixon MRI to detect subclinical inflammation in clinically suspect arthralgia as a risk factor for rheumatoid arthritis development: should we image one or two hands?

Daniek van der Kaaij, Stijn Claassen, Hanna W van Steenbergen

|Feb 20, 2026
Rheumatologist's expertise in estimating risk of developing rheumatoid arthritis in patients with clinically suspect arthralgia: what is the value?

Stijn Claassen, Hanna W van Steenbergen, Annette H M van der Helm-Van Mil

|Feb 11, 2026
Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis.

Sumera Qureshi, Maryam Adas, Phoebe J Cope

|Jan 20, 2026
Which arthralgia patients benefit most in reduction of subclinical joint inflammation by methotrexate treatment: results from the TREAT EARLIER trial.

Stijn Claassen, Quirine A Dumoulin, Herman K Glas

Pageof 13

Frequent Collaborators

24 joint publications

Elise van Mulligen

24 joint publications

Php de Jong

11 joint publications

Anna M P Boeren

11 joint publications

Hanna W van Steenbergen